alliin has been researched along with s 8932 in 1 studies
| Studies (alliin) | Trials (alliin) | Recent Studies (post-2010) (alliin) | Studies (s 8932) | Trials (s 8932) | Recent Studies (post-2010) (s 8932) |
|---|---|---|---|---|---|
| 149 | 4 | 71 | 1,246 | 52 | 1,207 |
| Protein | Taxonomy | alliin (IC50) | s 8932 (IC50) |
|---|---|---|---|
| NS5 | Zika virus | 1.36 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.525 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, B; Li, T | 1 |
1 other study(ies) available for alliin and s 8932
| Article | Year |
|---|---|
Discovery of alliin as a putative inhibitor of the main protease of SARS-CoV-2 by molecular docking.
Topics: Adenosine Monophosphate; Alanine; Antimalarials; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus 3C Proteases; Cysteine; Cysteine Endopeptidases; Molecular Docking Simulation; Ritonavir; SARS-CoV-2; Viral Nonstructural Proteins | 2020 |